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ABSTRACT: Inherited retinal dystrophies are a ma-
jor cause of childhood blindness. Here, we describe
the identification of a homozygous frameshift mutation
(c.1194_1195delAG, p.Arg398Serfs∗9) in TUB in a
child from a consanguineous UK Caucasian family in-
vestigated using autozygosity mapping and whole-exome
sequencing. The proband presented with obesity, night
blindness, decreased visual acuity, and electrophysiologi-
cal features of a rod cone dystrophy. The mutation was
also found in two of the proband’s siblings with retinal
dystrophy and resulted in mislocalization of the truncated
protein. In contrast to known forms of retinal dystrophy,
including those caused by mutations in the tubby-like pro-
tein TULP-1, loss of function of TUB in the proband and
two affected family members was associated with early-
onset obesity, consistent with an additional role for TUB
in energy homeostasis.
Hum Mutat 35:289–293, 2014. Published 2013 Wiley Periodi-
cals, Inc.∗
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Retinitis pigmentosa (RP) describes a genetically heterogeneous
group of disorders characterized by night blindness, early periph-
eral visual field loss, and subsequent loss of central vision, leading
to severe visual impairment. RP can be inherited in an autosomal-
dominant, autosomal-recessive, or X-linkedmanner andmutations
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in over 60different genes have been identified todate [denHollander
et al., 2010]. However, a significant proportion of RP remains ge-
netically unexplained. RP may be seen in combination with obesity
in Bardet–Biedl syndrome and Alstrom syndrome. These disorders,
and other forms of RP, are referred to as “ciliopathies” as they are
caused by mutations in genes important for the generation and
maintenance of cilia [Waters and Beales, 2011].
The Tubby-like proteins (TUB, TULP1, TULP2, and TULP3)
are a unique family of proteins that share a highly conserved
C-terminal domain [Carroll et al., 2004]. They take their name
from the tubby strain of obese mice in which a recessive, loss-of-
function mutation in Tub causes retinal and cochlear degeneration,
obesity, and insulin resistance [Coleman and Eicher, 1990; Kleyn
et al., 1996; Noben-Trauth et al., 1996]. Recessively inherited mu-
tations in TULP1, which is highly expressed in the retina and im-
plicated in rhodopsin transport, are found in approximately 1% of
patients with RP [Hagstrom et al., 1998; den Hollander et al., 2007].
However, disease-associated mutations involving other TUB family
members have not been identified to date in humans.
An 11-year-old male from a consanguineous UK Caucasian fam-
ily presentedwith deteriorating vision for 2 years. Visual acuity (VA)
was 6/12 in the right eye and no perception of light (NPL) in the
left eye. He had a bilateral myopic and astigmatic refractive error
and retinal examination demonstrated a “blonde” fundus in the
right eye and total retinal detachment with vitreous hemorrhage in
the left eye. When reviewed at age 18 years, his best corrected VA
was 6/9 in the right eye and NPL in the left eye. He had a bilat-
eral myopic and astigmatic refractive error (right eye –1.25 dioptre
sphere with –4.25 dioptre cylinder at 16◦, and left eye –1.00 dioptre
sphere with –4.00 dioptre cylinder at 170◦). Hardy Rand and Ritler
color vision testing of the right eye revealed a general disturbance of
color vision affecting protan, deutan, and tritan axes. Funduscopy
of the right eye demonstrated widespread retinal pigment epithelial
atrophy, generalized retinal pallor, arteriolar attenuation, fine pe-
ripheral pigmentary mottling and white dots throughout the retina,
with sparing of the macula (Fig. 1A). There was no intraretinal pig-
ment migration and no vitreoretinal interface abnormalities were
identified on clinical examination or on optical coherence tomog-
raphy (OCT) imaging in this eye. Funduscopy of the left eye showed
a total retinal detachment. The visual field in the right eye, tested
with Goldmann perimetry, was reduced to the central 15◦.
Full-field electroretinography (ERG) in the proband demon-
strated a nonrecordable ERG in the left eye and severe loss of
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Figure 1. Identification of a homozygous frameshiftmutation in TUBandclinical phenotype.A:Ocular images of proband. (i) Fundus photograph of
right eye. (ii) Fundus autofluorescence of right eye. (iii) Spectral domain OCT image of right eye. Arrows mark the junction of preserved and nonpre-
served IS/OS junctions.B:Pedigreeofaffected family. Theproband (II.4) is indicatedwithanarrow.Solid symbols represent familymemberswith reti-
nal dystrophy (RD), open symbols unaffected familymembers. Circles represent females, and squares representmales.C:Schematic showing chro-
mosome 11, blocks of homozygosity identified in the proband’s DNA (generated using AutoSNPa), and the location and gene structure of TUB. Black
and yellowbars indicate homozygous andheterozygous single-nucleotide polymorphismcalls, respectively. The three splice variants that arise from
the TUB gene are indicated (TUB001 (Ensembl ENST00000534099), TUB002 (Ensembl ENST00000305253 and TUB003 [Ensembl ENST00000299506]).
D: Sequencing reads showing the homozygous mutation in TUB that was identified by exome sequencing (Integrative Genomics Viewer).
E: Sequence chromatogram for the proband.
function in the right eye with absent rod responses and a small
residual cone response, in keeping with a severe generalized rod-
cone dystrophy. Retinal OCT imaging demonstrated preservation
of the photoreceptor inner segment/outer segment (IS/OS) junc-
tion at the fovea, with loss of this layer in the parafoveal re-
gion (Fig. 1A). This corresponded with the fundus autofluores-
cence (FAF) image, which demonstrated an annulus of hyperaut-
ofluorescence, commonly seen in patients with RP (Fig. 1A). At
the age of 18 years, the patient was obese with a body mass in-
dex (BMI) of 30 kg/m2, normal random glucose (5.0 mmol/L),
290 HUMANMUTATION, Vol. 35, No. 3, 289–293, 2014
HbA1c (39 mmol/mol), triglycerides (1.6 mmol/L), total choles-
terol (4.3 mmol/L), and high density lipoprotein (HDL) cholesterol
(1.1 mmol/L). There were no additional clinical features sugges-
tive of Bardet–Biedl syndrome or Alstrom syndrome. Of note, no
hearing problems were reported, although the patient had mild
learning difficulties.
On the basis of the proband’s consanguineous ancestry, his DNA
was analyzed using homozygosity mapping [Lander and Botstein,
1987] (for details of experimental procedures, see Supp. Methods).
Five chromosomal segments over 5 Mb were identified but none of
these regions included knownRP-associated genes (Supp. Table S1).
Although four retinal disease-associated genes were found to be
present in the 20.4-Mb region (CTSD, TPP1, TEAD1, andUSH1C),
subsequent sequencing data demonstrated that the proband did not
possess any disease-causing variants in these genes. Exon capture
and high-throughput sequencing of the subject’s DNA was then
performed using solution-phase Agilent SureSelect 38-Mb exome
capture. Average sequencing depth on target was 43 with 78.4%
of the targeted region covered with a minimum read depth of
10. On the basis of the prior belief that RP-related mutations are
rare; calls with minor allele frequencies greater than 0.5% in the
1000 genomes dataset were filtered. When prioritizing homozy-
gous, presumed loss-of-function sequence alterations, we identi-
fied a homozygous frameshift variant in TUB (MIM #601197)
c.1194 1195delAG, p.Arg398Serfs∗9 (numbered according to En-
sembl transcript ENST00000299506) (Supp. Table S2). This variant
was located in the second largest region of homozygosity (Supp.
Table S1) and was verified by Sanger sequencing (Fig. 1C). The TUB
variant identified in this study has been submitted to a TUB-specific
database (www.lovd.nl/TUB). No potentially pathogenic variants
were identified by exome sequencing in any genes currently known
to be associated with RP or in any other retinal disease-associated
genes (RetNet; http://www.sph.uth.tmc.edu/retnet).
The proband’s older brother (II.3) and younger sister (II.5) were
also found toharbor theTUBvariant in thehomozygous state (Supp.
Fig. S1). They both had reduced vision (6/18 both eyes in the brother
and 6/9 right, 6/12 left in the sister) andmyopic astigmatic refractive
errors (Supp. Table S3). The 21-year-old brother was not aware of
any ocular problems but was found to have bilateral symmetrical
widespread RPE atrophy, fine pigmentary mottling, and white dots
throughout the retina (Supp. Fig. S1). There was hypofluorescent
mottling along the vascular arcades but a normal foveal autofluo-
rescence signal. The OCT demonstrated a preserved photoreceptor
IS/OS layer at the fovea with outer retinal debris at the level of the
RPE in the parafoveal region. The retina in the 9-year-old sister,
who was asymptomatic, had bilateral widespread RPE atrophy but
the pigmentary mottling was confined to the inferior retina. OCT
and FAF imaging were normal. While the brother had a BMI in
the normal range (23 kg/m2) at the age of 21 years, the sister was
classified as obese at the age of 9 years, falling into the 98th centile
for age and gender. It is not clear why the brother had a milder
retinal phenotype and a normal BMI at the age of 21, although it
is possible that environmental factors or other genetic modifiers
may have influenced his phenotype. Unfortunately, data regarding
his BMI in early childhood were not available and therefore it was
not possible to ascertain whether obesity was a feature at a young
age. Both the father (I.1), mother (I.2), and one unaffected sibling
(II.2) were heterozygous for the variant and had BMIs of 30, 24,
and 20 kg/m2, respectively (Supp. Table S3). The patient and family
did not consent to further phenotypic studies such as smell acuity,
auditory testing, and metabolic studies.
We screened TUB using Sanger sequencing in 96 additional
probands with childhood-onset autosomal-recessive RP, where pre-
vious genetic investigations had not identified the causative gene,
and in 55 patients with severe obesity and a variety of ocular phe-
notypes from the Genetics of Obesity Study (GOOS); no addi-
tional potentially pathogenic variants were found. In a previous
study, sequencing of TUB in 294 subjects with recessive RP did
not identify any causative mutations [Xi et al., 2006] and the TUB
p.Arg398Serfs∗9 variant was also not present in over 6,000 publicly
available exomes (NHLBI exome variant server). In addition, only
two frameshift variants, which are likely to result in complete loss
of function of TUB, were found in 12,982 alleles (NHLBI exome
variant server), indicating that homozygous loss of function of TUB
is rare (estimated frequency <1/107 individuals).
The TUB p.Arg398Serfs∗9 variant falls within the highly con-
served C-terminal tubby domain that is found in all TUB family
members and results in a truncated form of TUB (Fig. 1, Supp.
Fig. S2). In fact, it would be predicted to lead to an even more
severe truncation than that caused by the mutation originally iden-
tified in the tubby mouse. We found that when transfected into
HEK293 cells, the p.Arg398Serfs∗9 variant was expressed but at a
reduced level compared with wild-type (WT) TUB (Fig. 2B). While
GFP–TUBWTwas detected within the cytoplasm and at the plasma
membrane, GFP–TUB p.Arg398Serfs∗9 localized predominantly to
the nucleus (Fig. 2C). Subcellular fractionation also confirmed this
mislocalization; the level ofGFP–TUBp.Arg398Serfs∗9was reduced
in the plasma membrane fraction but increased in the chromatin-
bound fraction (Fig. 2D). GFP–TUB p.Arg398Serfs∗9, but not WT,
was also found in the insoluble fraction of the pellet, potentially
indicating that it may form aggregates within cells.
We also analyzed the distribution of TUB in the human retina by
immunohistochemistry on cryosections using an antibody raised
against the N-terminus of TUB. We found strong TUB expression
in the nuclei of the ganglion–cell layer as well as the inner and the
outer nuclear layer, and moderate staining in the inner segment
of photoreceptor cells (Fig. 2E). This contrasts with expression of
the related Tub family member, TULP1, which is reported to be
limited to photoreceptor cells only [Hagstrom et al., 1999, 2001;
Ikeda et al., 1999].Double immunofluorescence labelingofTUBand
molecular markers of ciliary compartments, namely anti-centrin3
(connecting cilium, basal body and adjacent centriole marker
[Trojan et al., 2008]) and anti-rootletin (photoreceptor ciliary root-
let marker [Yang et al., 2002]), revealed localization of TUB at the
base of the photoreceptor cilium and the ciliary rootlet, projecting
through the inner segment of the photoreceptor cell (Fig. 2E).
The presence of TUB at the ciliary base and ciliary rootlet of
photoreceptor cells is similar to that described in previous studies
on TULP1 [Hagstrom et al., 1999, 2001; Ikeda et al., 1999]. Both
compartments are thought to participate in the transport of cil-
iary cargo [Nachury et al., 2010; Gilliam et al., 2012] and there is
growing evidence that TUB and other TUB family members play
a role in the delivery of G protein-coupled receptors (GPCRs) to
cilia [Mukhopadhyay and Jackson, 2011; Sun et al., 2012]. Defective
rhodopsin transport is the likely mechanism by which photorecep-
tor degeneration occurs [Sun et al., 2012]. TULP-3 regulates GPCR
trafficking to primary cilia through its interaction with components
of the IFT-A complex, and mutation of the C-terminal domain in
TULP-3 in mice results in reduced ciliary localization of the GPCR,
MCHR1 [Mukhopadhyay et al., 2010]. While comparable studies
are not possible in humans, it is plausible that the p.Arg398Serfs∗9
variant, which disrupts the C-terminal domain, affects GPCR traf-
ficking.
The presence of early-onset obesity in the proband and affected
family members, in addition to RP, is consistent with the phenotype
seen in Tubmutant mice, although this was not as severe as in other
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Figure 2. Functional characterization of TUB mutation. A: Schematic representation of the TUB WT and frameshift mutant proteins. B: HEK293
cellswere transfectedwith the indicated constructs and resulting lysates subjected to immunoblottingwith the indicated antibodies.C: Transfected
HEK293 cells were fixed and localization of TUB proteins was determined by immunofluorescent staining. Green, GFP—Tub; red, plasmamembrane
marker (wheatgerm agglutinin alexa fluor 594); and blue, DAPI staining of nuclear DNA. D: Subcellular fractionation of HEK293 cells transfected
with WT or mutant (MUT) GFP–TUB. E: Localization of TUB in human retinal cryosections. (i) Differential interference contrast (DIC) image and
indirect immunofluorescence of anti-TUB (red). (ii) Merged images of double immunofluorescence of TUB (red), Centrin3 (Cen, green), and DAPI
(blue). (iii and iv) High-magnification images of a single photoreceptor ciliary apparatus. Double labeling of (iii) TUB (red) and Centrin3 (green) and
(iv) rootletin (red) and Centrin (green). Arrow indicates the centriole, CR, ciliary rootlet. (v) Labeling of TUB (red) and DAPI (blue) showing TUB
localization in the euchromatin (arrowhead) of nuclei. (vi) Schematic cartoon of TUB (red) and Cen (green) localization in the photoreceptor ciliary
region. TUB and Cen colocalize at the centriole (yellow). TUB and rootletin distribution is identical. BB, basal body; CC, connecting cilium; CE,
centriole; IPL, inner plexiform layer; OS, outer segment; OPL, outer plexiform layer. Scale bars: (i)–(ii) 25 μm; (iv) 0.5 μm; and (v) 5 μm.
292 HUMANMUTATION, Vol. 35, No. 3, 289–293, 2014
genetic forms of obesity. It has recently been shown that the target-
ing of two neuronal GPCRs, SSTR3, and MCHR1 to neuronal cilia
is defective in Tubmutant mice [Sun et al., 2012]. The observation
that MCHR1 localization is disrupted is of particular interest as it
is involved in the regulation of energy intake and expenditure. In
addition, TUB appears to be involved in mediating the effects of
insulin and leptin within the hypothalamus [Prada et al., 2013].
Previous studies in mice have demonstrated that Tub is expressed
in regions of the hypothalamus involved in feeding behavior and
energy homeostasis [Sahly et al., 1998; Ikeda et al., 2000], and we
also observed widespread TUB expression in human brain regions
including the hypothalamus, as well as the retina (data not shown).
Although TULP1 is also expressed in the same hypothalamic re-
gions as TUB, obesity has not been reported in other families with
TULP1-associatedRPnor inTULP1–/– mice [Lewis et al., 1999; Ikeda
et al., 2000]. It is possible that this is due to discrete differences in
their expression; previous reports have shown that in hypothala-
mic neurons TUB immunoreactivity is detected in the nucleolus of
the nucleus, whereas TULP1 is only observed in distinct structures
within the nucleus. However, further investigation will be neces-
sary to fully understand the mechanisms underlying the shared and
disparate phenotypes caused bymutations inTUB familymembers.
In summary, we describe a new ciliopathy characterized by retinal
dystrophy and early-onset obesity due to a homozygous variant in
TUB. Although further studies will be needed to fully elucidate the
molecular functions of TUB, it is striking that the TUB variant
reported here and all TULP1 mutations described to date, disrupt
the C-terminal domain found in all TUB family members. Further
studies will be needed to test whether, as in mice, human TUB plays
a role in the trafficking of GPCRs to cilia and in the modulation of
signaling by hypothalamic GPCRs involved in energy homeostasis.
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